M. Scott Harris
2022
In 2022, M. Scott Harris earned a total compensation of $1.4M as Chief Medical Officer at PharmAthene, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $182,400 |
|---|---|
| Option Awards | $572,395 |
| Salary | $456,000 |
| Stock Awards | $234,183 |
| Other | $4,640 |
| Total | $1,449,618 |
Harris received $572.4K in option awards, accounting for 39% of the total pay in 2022.
Harris also received $182.4K in non-equity incentive plan, $456K in salary, $234.2K in stock awards and $4.6K in other compensation.
Rankings
In 2022, M. Scott Harris' compensation ranked 2,285th out of 5,676 executives tracked by ExecPay. In other words, Harris earned more than 59.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,285 out of 5,676 | 60th |
Division Manufacturing | 1,235 out of 3,084 | 60th |
Major group Chemicals And Allied Products | 548 out of 1,399 | 61st |
Industry group Drugs | 503 out of 1,300 | 61st |
Industry Pharmaceutical Preparations | 365 out of 942 | 61st |
Source: SEC filing on August 16, 2023.
Harris' colleagues
We found three more compensation records of executives who worked with M. Scott Harris at PharmAthene in 2022.